Faculty Profile

David W. Hutton, PhD

David W. Hutton, PhD

  • Associate Professor
  • Health Management and Policy
  • School of Public Health

  • Associate Professor of Global Public Health
  • School of Public Health
  • Associate Professor
  • Industrial and Operations Engineering
  • College of Engineering
  • 1415 Washington Heights
  • M3525 SPH II
  • Ann Arbor, Michigan 48109-2029

David Hutton holds a PhD from Stanford's department of Management Science and Engineering with a focus on health policy modeling. Prior to joining Stanford's PhD program, David worked for a consulting company that focused on mathematical modeling and for several silicon valley software companies. David's current research is focused on health policy and medical decision making, in particular the use of mathematical models to assist with the allocation of resources for health. His research and influence on national and international hepatitis B policy earned him the first place prize in the "Doing Good with Good OR student paper competition" from the Institute for Operations Research and Management Science.  He has served as a consultant, advisor, and/or collaborator with the World Health Organization, the US Department of Health and Human Services, and the Centers for Disease Control and Prevention.

  • PhD, Management Science and Engineering, Stanford University, 2010
  • M.S., Industrial Engineering, Stanford University, 1999
  • B.S., Industrial Engineering, Stanford University, 1998
  • B.A., Economics, Stanford University, 1998

  • Cost-effectiveness analysis

    I am interested in evaluating the cost-effectiveness of new public health policies and the use of new drugs and devices. I am interested in interventions with uncertain or complex outcomes.  Specifically, I have conducted cost-effectiveness analyses of infectious disease interventions, chronic disease interventions, and analyses of new drugs and devices. 

  • Patient education and decision-making: breast cancer

  • Stranges PM, Hutton DW, Collins CD (2013). Cost-effectiveness Analysis Evaluating Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States Value in Health 297-304.

  • Society for Medical Decision Making (SMDM)
  • Institute for Operations Research and Management Science (INFORMS)